Eloxx Pharmaceuticals Inc. (ELOX) stock fell during current market trading. What’s new?
Eloxx Pharmaceuticals Inc. (NASDAQ: ELOX) stock declined by 14.77% in the current market trading. Eloxx Pharmaceuticals, Inc. is working on developing new ribosome modulating agents (RMAs) using its TURBO-ZM chemical technology platform and its portfolio of Eukaryotic Ribosome Selective Glycosides. ELX-02, Eloxx’s primary investigational drug candidate, is a small molecule therapeutic candidate that aims to […]
Eloxx Pharmaceuticals, Inc. (ELOX) Stock Trending Higher Following Funding Award from Cystic Fibrosis Foundation
Eloxx Pharmaceuticals, Inc. (ELOX) stock prices were up by 5.67% as of the market closing on May 27th, 2021, bringing the price per share up to USD$1.49 at the end of the trading day. Subsequent pre-market fluctuations have seen the stock rise by 7.38%, bringing it up to USD$1.60. Acquisition of Zikani Therapeutics April 1st, […]
Eloxx Pharmaceuticals, Inc. (ELOX) stock gains during pre-market session. Here’s to know why?
Eloxx Pharmaceuticals, Inc. (NASDAQ: ELOX) stock gained by 2.92% at last close while the ELOX stock price rises by 2.84% in the pre-market trading. Eloxx Pharmaceuticals is working on developing novel Ribosome Modulating Agents (RMAs) using its groundbreaking TURBO-ZMTM chemistry technology platform and its library of Eukaryotic Ribsome Selective Glycosides (ERSGs). What is happening? ELOX […]
